Cargando…
The Side Effects and Adverse Clinical Cases Reported after COVID-19 Immunization
COVID-19 remains a deadly disease that poses a serious threat to humanity. COVID-19 vaccines protect the public and limit viral spread. However, public acceptance is significantly dependent on the efficacy and side effects (SEs) of the vaccinations being produced. Four important mechanisms have been...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031559/ https://www.ncbi.nlm.nih.gov/pubmed/35455237 http://dx.doi.org/10.3390/vaccines10040488 |
_version_ | 1784692419891036160 |
---|---|
author | Rabail, Roshina Ahmed, Waqar Ilyas, Madiha Rajoka, Muhammad Shahid Riaz Hassoun, Abdo Khalid, Abdur Rauf Khan, Moazzam Rafiq Aadil, Rana Muhammad |
author_facet | Rabail, Roshina Ahmed, Waqar Ilyas, Madiha Rajoka, Muhammad Shahid Riaz Hassoun, Abdo Khalid, Abdur Rauf Khan, Moazzam Rafiq Aadil, Rana Muhammad |
author_sort | Rabail, Roshina |
collection | PubMed |
description | COVID-19 remains a deadly disease that poses a serious threat to humanity. COVID-19 vaccines protect the public and limit viral spread. However, public acceptance is significantly dependent on the efficacy and side effects (SEs) of the vaccinations being produced. Four important mechanisms have been examined for COVID-19 vaccines: DNA-based, mRNA-based, protein-based, and inactivated viruses. Vaccination safety research was formerly limited to manufacturer-sponsored studies, but numerous additional cross-sectional survey-based studies conducted globally have contributed to the generation of vaccine-related safety data reports. Twenty-seven studies and twenty-four case reports published-up till 2021 were overviewed for the presentation of SEs and their severity. Injection site pain remained the most dominant localized SE, while headache and fatigue were the most prevalent systemic SEs. Most studies reported that all vaccinations were safe, with very little or no adverse effects, but the nature of SEs was reported to be more persistent in DNA- and mRNA-based vaccines, while inactivated viral vaccines were associated with longer-duration SEs. Overall, SEs were found to be more dominant in women and youngsters. Case reports of adverse reactions have also been documented, but there is still a need to find out their pathological linkage with the COVID-19 vaccination. |
format | Online Article Text |
id | pubmed-9031559 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-90315592022-04-23 The Side Effects and Adverse Clinical Cases Reported after COVID-19 Immunization Rabail, Roshina Ahmed, Waqar Ilyas, Madiha Rajoka, Muhammad Shahid Riaz Hassoun, Abdo Khalid, Abdur Rauf Khan, Moazzam Rafiq Aadil, Rana Muhammad Vaccines (Basel) Review COVID-19 remains a deadly disease that poses a serious threat to humanity. COVID-19 vaccines protect the public and limit viral spread. However, public acceptance is significantly dependent on the efficacy and side effects (SEs) of the vaccinations being produced. Four important mechanisms have been examined for COVID-19 vaccines: DNA-based, mRNA-based, protein-based, and inactivated viruses. Vaccination safety research was formerly limited to manufacturer-sponsored studies, but numerous additional cross-sectional survey-based studies conducted globally have contributed to the generation of vaccine-related safety data reports. Twenty-seven studies and twenty-four case reports published-up till 2021 were overviewed for the presentation of SEs and their severity. Injection site pain remained the most dominant localized SE, while headache and fatigue were the most prevalent systemic SEs. Most studies reported that all vaccinations were safe, with very little or no adverse effects, but the nature of SEs was reported to be more persistent in DNA- and mRNA-based vaccines, while inactivated viral vaccines were associated with longer-duration SEs. Overall, SEs were found to be more dominant in women and youngsters. Case reports of adverse reactions have also been documented, but there is still a need to find out their pathological linkage with the COVID-19 vaccination. MDPI 2022-03-22 /pmc/articles/PMC9031559/ /pubmed/35455237 http://dx.doi.org/10.3390/vaccines10040488 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Rabail, Roshina Ahmed, Waqar Ilyas, Madiha Rajoka, Muhammad Shahid Riaz Hassoun, Abdo Khalid, Abdur Rauf Khan, Moazzam Rafiq Aadil, Rana Muhammad The Side Effects and Adverse Clinical Cases Reported after COVID-19 Immunization |
title | The Side Effects and Adverse Clinical Cases Reported after COVID-19 Immunization |
title_full | The Side Effects and Adverse Clinical Cases Reported after COVID-19 Immunization |
title_fullStr | The Side Effects and Adverse Clinical Cases Reported after COVID-19 Immunization |
title_full_unstemmed | The Side Effects and Adverse Clinical Cases Reported after COVID-19 Immunization |
title_short | The Side Effects and Adverse Clinical Cases Reported after COVID-19 Immunization |
title_sort | side effects and adverse clinical cases reported after covid-19 immunization |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031559/ https://www.ncbi.nlm.nih.gov/pubmed/35455237 http://dx.doi.org/10.3390/vaccines10040488 |
work_keys_str_mv | AT rabailroshina thesideeffectsandadverseclinicalcasesreportedaftercovid19immunization AT ahmedwaqar thesideeffectsandadverseclinicalcasesreportedaftercovid19immunization AT ilyasmadiha thesideeffectsandadverseclinicalcasesreportedaftercovid19immunization AT rajokamuhammadshahidriaz thesideeffectsandadverseclinicalcasesreportedaftercovid19immunization AT hassounabdo thesideeffectsandadverseclinicalcasesreportedaftercovid19immunization AT khalidabdurrauf thesideeffectsandadverseclinicalcasesreportedaftercovid19immunization AT khanmoazzamrafiq thesideeffectsandadverseclinicalcasesreportedaftercovid19immunization AT aadilranamuhammad thesideeffectsandadverseclinicalcasesreportedaftercovid19immunization AT rabailroshina sideeffectsandadverseclinicalcasesreportedaftercovid19immunization AT ahmedwaqar sideeffectsandadverseclinicalcasesreportedaftercovid19immunization AT ilyasmadiha sideeffectsandadverseclinicalcasesreportedaftercovid19immunization AT rajokamuhammadshahidriaz sideeffectsandadverseclinicalcasesreportedaftercovid19immunization AT hassounabdo sideeffectsandadverseclinicalcasesreportedaftercovid19immunization AT khalidabdurrauf sideeffectsandadverseclinicalcasesreportedaftercovid19immunization AT khanmoazzamrafiq sideeffectsandadverseclinicalcasesreportedaftercovid19immunization AT aadilranamuhammad sideeffectsandadverseclinicalcasesreportedaftercovid19immunization |